Pneumococcal 23-polyvalent vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with pneumococcal 23-polyvalent vaccine
N
- natalizumab
- Navelbine (vinorelbine)
- naxitamab
- nelarabine
- Neoral (cyclosporine)
- Neosar (cyclophosphamide)
- Neutrexin (trimetrexate)
- nilotinib
- Ninlaro (ixazomib)
- Nipent (pentostatin)
- niraparib
- Novantrone (mitoxantrone)
- Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313) (sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313))
- Novavax COVID-19 Vaccine (sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant)
- Nulojix (belatacept)
More about pneumococcal 23-polyvalent vaccine
- pneumococcal 23-polyvalent vaccine consumer information
- Check interactions
- Compare alternatives
- Reviews (18)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bacterial vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.